United Therapeutics Corporation - stock earnings
UTHR Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 31, 2024 BeforeMarket | - / - | 643.0 million | - / 678.1 million | 728.6 million |
UTHR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 306.6 million USD | 677.7 million USD |
| 2023Q4 | 217.1 million USD | 614.7 million USD |
| 2023Q3 | 267.6 million USD | 609.4 million USD |
| 2023Q2 | 259.2 million USD | 596.5 million USD |
| 2023Q1 | 240.9 million USD | 506.9 million USD |
| 2022Q4 | 132.1 million USD | 491.5 million USD |
| 2022Q3 | 239.3 million USD | 516.0 million USD |
| 2022Q2 | 116.0 million USD | 466.9 million USD |
| 2022Q1 | 239.9 million USD | 461.9 million USD |
| 2021Q4 | 112.2 million USD | 415.2 million USD |
| 2021Q3 | 162.7 million USD | 444.7 million USD |
| 2021Q2 | 172.6 million USD | 446.5 million USD |
| 2021Q1 | 28.3 million USD | 379.1 million USD |
| 2020Q4 | 98.8 million USD | 384.9 million USD |
| 2020Q3 | 171.2 million USD | 380.1 million USD |
| 2020Q2 | 107.1 million USD | 362.0 million USD |
| 2020Q1 | 137.7 million USD | 356.3 million USD |
| 2019Q4 | 52.6 million USD | 311.1 million USD |
| 2019Q3 | 132.4 million USD | 401.5 million USD |
| 2019Q2 | 205.1 million USD | 373.6 million USD |
| 2019Q1 | -494.6 million USD | 362.6 million USD |
| 2018Q4 | 65.3 million USD | 381.4 million USD |
| 2018Q3 | 106.5 million USD | 412.7 million USD |
| 2018Q2 | 172.9 million USD | 444.5 million USD |
| 2018Q1 | 244.5 million USD | 389.2 million USD |
| 2017Q4 | 19.0 million USD | 464.7 million USD |
| 2017Q3 | 276.3 million USD | 445.5 million USD |
| 2017Q2 | -56.0 million USD | 444.6 million USD |
| 2017Q1 | 178.6 million USD | 370.5 million USD |
| 2016Q4 | 110.3 million USD | 409.0 million USD |
| 2016Q3 | 161.8 million USD | 408.2 million USD |
| 2016Q2 | 206.1 million USD | 412.6 million USD |
| 2016Q1 | 235.5 million USD | 369.0 million USD |
| 2015Q4 | 104.6 million USD | 404.9 million USD |
| 2015Q3 | 464.4 million USD | 386.2 million USD |
| 2015Q2 | 99.2 million USD | 347.2 million USD |
| 2015Q1 | -16.6 million USD | 327.5 million USD |
| 2014Q4 | 115.9 million USD | 346.4 million USD |
| 2014Q3 | -25.2 million USD | 330.0 million USD |
| 2014Q2 | 111.9 million USD | 322.8 million USD |
| 2014Q1 | 137.5 million USD | 289.4 million USD |
| 2013Q4 | -30.3 million USD | 289.0 million USD |
| 2013Q3 | 62.7 million USD | 302.2 million USD |
| 2013Q2 | 79.9 million USD | 280.6 million USD |
| 2013Q1 | 62.3 million USD | 245.1 million USD |
| 2012Q4 | 83.3 million USD | 243.8 million USD |
| 2012Q3 | 78.1 million USD | 242.5 million USD |
| 2012Q2 | 72.3 million USD | 225.6 million USD |
| 2012Q1 | 70.8 million USD | 204.2 million USD |
| 2011Q4 | 43.2 million USD | 195.2 million USD |
| 2011Q3 | 84.4 million USD | 201.7 million USD |
| 2011Q2 | 73.9 million USD | 183.8 million USD |
| 2011Q1 | 16.4 million USD | 165.6 million USD |
| 2010Q4 | 9.5 million USD | 166.5 million USD |
| 2010Q3 | 39.7 million USD | 171.0 million USD |
| 2010Q2 | 37.7 million USD | 137.5 million USD |
| 2010Q1 | 18.9 million USD | 128.9 million USD |
| 2009Q4 | -3.3 million USD | 108.9 million USD |
| 2009Q3 | 11.9 million USD | 97.2 million USD |
| 2009Q2 | -2.3 million USD | 84.0 million USD |
| 2009Q1 | 13.2 million USD | 79.7 million USD |
| 2008Q4 | -81.1 million USD | 75.9 million USD |
| 2008Q3 | 12.6 million USD | 75.0 million USD |
| 2008Q2 | 14.3 million USD | 68.6 million USD |
| 2008Q1 | 11.4 million USD | 62.0 million USD |
| 2007Q4 | 2.0 million USD | 59.9 million USD |
| 2007Q3 | 14.8 million USD | 59.0 million USD |
| 2007Q2 | 5.8 million USD | 51.8 million USD |
| 2007Q1 | -2.8 million USD | 40.2 million USD |
| 2006Q4 | 55.5 million USD | 45.8 million USD |
| 2006Q3 | 8.5 million USD | 40.4 million USD |
| 2006Q2 | 7.7 million USD | 40.2 million USD |
| 2006Q1 | 2.3 million USD | 33.2 million USD |
| 2005Q4 | 29.4 million USD | 29.6 million USD |
| 2005Q3 | 15.8 million USD | 33.0 million USD |
| 2005Q2 | 12.2 million USD | 30.1 million USD |
| 2005Q1 | 7.7 million USD | 23.2 million USD |
| 2004Q4 | 6.9 million USD | 21.6 million USD |
| 2004Q3 | 6.3 million USD | 20.0 million USD |
| 2004Q2 | 4.1 million USD | 18.3 million USD |
| 2004Q1 | -1.8 million USD | 13.7 million USD |
| 2003Q4 | -3.2 million USD | 13.6 million USD |
| 2003Q3 | -1.3 million USD | 15.0 million USD |
| 2003Q2 | -2.4 million USD | 14.0 million USD |
| 2003Q1 | -3.0 million USD | 10.7 million USD |
| 2002Q4 | -2.6 million USD | 12.0 million USD |
| 2002Q3 | -12.2 million USD | 5.1 million USD |
| 2002Q2 | -3.2 million USD | 11.6 million USD |
| 2002Q1 | -5.7 million USD | 1.4 million USD |
| 2001Q4 | -7.4 million USD | 1.6 million USD |
| 2001Q3 | -9.8 million USD | 1.3 million USD |
| 2001Q2 | -10.6 million USD | 1.3 million USD |
| 2001Q1 | -9.4 million USD | 1.5 million USD |
| 2000Q4 | -31.9 million USD | 789667 USD |
| 2000Q3 | -7.0 million USD | 403891 USD |
| 2000Q2 | -28.8 million USD | 546303 USD |
| 2000Q1 | -7.9 million USD | 309397 USD |
| 1999Q4 | -8.8 million USD | 200000 USD |
| 1999Q3 | -6.4 million USD | 100000 USD |
| 1999Q2 | -6.1 million USD | 100000 USD |
| 1999Q1 | -12.2 million USD | 100000 USD |
UTHR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 984.8 million USD | 2.3 billion USD |
| 2022 | 727.3 million USD | 1.9 billion USD |
| 2021 | 475.8 million USD | 1.7 billion USD |
| 2020 | 514.8 million USD | 1.5 billion USD |
| 2019 | -104.5 million USD | 1.4 billion USD |
| 2018 | 589.2 million USD | 1.6 billion USD |
| 2017 | 417.9 million USD | 1.7 billion USD |
| 2016 | 713.7 million USD | 1.6 billion USD |
| 2015 | 651.6 million USD | 1.5 billion USD |
| 2014 | 340.1 million USD | 1.3 billion USD |
| 2013 | 174.6 million USD | 1.1 billion USD |
| 2012 | 304.4 million USD | 916.1 million USD |
| 2011 | 217.9 million USD | 743.2 million USD |
| 2010 | 105.9 million USD | 603.8 million USD |
| 2009 | 19.5 million USD | 369.8 million USD |
| 2008 | -42.8 million USD | 281.5 million USD |
| 2007 | 19.9 million USD | 210.9 million USD |
| 2006 | 74.0 million USD | 159.6 million USD |
| 2005 | 65.0 million USD | 115.9 million USD |
| 2004 | 15.4 million USD | 73.6 million USD |
| 2003 | -10.0 million USD | 53.3 million USD |
| 2002 | -23.7 million USD | 30.1 million USD |
| 2001 | -37.3 million USD | 5.7 million USD |
| 2000 | -75.6 million USD | 2.0 million USD |
| 1999 | -33.5 million USD | 400000 USD |
| 1998 | -12.8 million USD | 100000 USD |
UTHR
Price: $274.26
52 week price:
Earnings Per Share: 21.12 USD
P/E Ratio: 11.62
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 115651
Ebitda: 331.7 millionMarket Capitalization: 11.8 billion